ECP
Elk Creek Partners’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $8.89M | Sell |
265,146
-6,036
| -2% | -$202K | 1.53% | 16 |
|
|
2019
Q4 | $12.3M | Sell |
271,182
-186,455
| -41% | -$8.45M | 1.41% | 16 |
|
|
2019
Q3 | $17.4M | Sell |
457,637
-42,432
| -8% | -$1.62M | 1.5% | 12 |
|
|
2019
Q2 | $21.7M | Sell |
500,069
-64,507
| -11% | -$2.81M | 1.63% | 6 |
|
|
2019
Q1 | $21.5M | Buy |
564,576
+28,382
| +5% | +$1.08M | 1.55% | 12 |
|
|
2018
Q4 | $23.1M | Sell |
536,194
-189,201
| -26% | -$8.14M | 1.91% | 7 |
|
|
2018
Q3 | $35.7M | Sell |
725,395
-643,665
| -47% | -$31.6M | 1.92% | 6 |
|
|
2018
Q2 | $43.9M | Buy |
1,369,060
+366,749
| +37% | +$11.8M | 2.41% | 2 |
|
|
2018
Q1 | $31.2M | Buy |
1,002,311
+341,520
| +52% | +$10.6M | 1.82% | 8 |
|
|
2017
Q4 | $30.2M | Buy |
660,791
+48,742
| +8% | +$2.23M | 1.77% | 7 |
|
|
2017
Q3 | $23M | Buy |
612,049
+59,393
| +11% | +$2.23M | 1.45% | 12 |
|
|
2017
Q2 | $26.4M | Buy |
552,656
+540
| +0.1% | +$25.8K | 1.71% | 8 |
|
|
2017
Q1 | $25.2M | Buy |
552,116
+104,259
| +23% | +$4.75M | 1.54% | 13 |
|
|
2016
Q4 | $14.5M | Sell |
447,857
-10,591
| -2% | -$342K | 0.98% | 37 |
|
|
2016
Q3 | $15.7M | Buy |
458,448
+23,749
| +5% | +$813K | 1.03% | 32 |
|
|
2016
Q2 | $14.7M | Buy |
434,699
+45,141
| +12% | +$1.52M | 1.04% | 34 |
|
|
2016
Q1 | $20.6M | Buy |
389,558
+44,758
| +13% | +$2.37M | 1.53% | 12 |
|
|
2015
Q4 | $26.5M | Sell |
344,800
-29,073
| -8% | -$2.23M | 1.88% | 6 |
|
|
2015
Q3 | $15.4M | Buy |
373,873
+302,173
| +421% | +$12.4M | 1.24% | 21 |
|
|
2015
Q2 | $5.07M | Buy |
+71,700
| New | +$5.07M | 0.46% | 96 |
|